WO2004059001A3 - Method for determining markers of human facial skin - Google Patents

Method for determining markers of human facial skin Download PDF

Info

Publication number
WO2004059001A3
WO2004059001A3 PCT/EP2003/014068 EP0314068W WO2004059001A3 WO 2004059001 A3 WO2004059001 A3 WO 2004059001A3 EP 0314068 W EP0314068 W EP 0314068W WO 2004059001 A3 WO2004059001 A3 WO 2004059001A3
Authority
WO
WIPO (PCT)
Prior art keywords
facial skin
human facial
markers
determining
cosmetic
Prior art date
Application number
PCT/EP2003/014068
Other languages
German (de)
French (fr)
Other versions
WO2004059001A2 (en
Inventor
Dirk Petersohn
Kordula Schlotmann
Thomas Gassenmeier
Olaf Holtkoetter
Marcus Conradt
Kay Hofmann
Original Assignee
Henkel Kgaa
Dirk Petersohn
Kordula Schlotmann
Thomas Gassenmeier
Olaf Holtkoetter
Marcus Conradt
Kay Hofmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa, Dirk Petersohn, Kordula Schlotmann, Thomas Gassenmeier, Olaf Holtkoetter, Marcus Conradt, Kay Hofmann filed Critical Henkel Kgaa
Priority to EP03789223A priority Critical patent/EP1573064A2/en
Priority to AU2003293839A priority patent/AU2003293839A1/en
Publication of WO2004059001A2 publication Critical patent/WO2004059001A2/en
Publication of WO2004059001A3 publication Critical patent/WO2004059001A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a method for determining the homeostasis of human facial skin in vitro, to test kits and biochips for determining markers of human facial skin, in addition to the use of proteins, mRNA molecules or fragments of proteins or mRNA molecules as markers of human facial skin. The invention also relates to a test method for detecting the effectiveness of cosmetic or pharmaceutical active substances for treating human facial skin in addition to a screening method for identifying cosmetic or pharmaceutical active substances for treating human facial skin and to a method for producing a cosmetic or pharmaceutical preparation for treating human facial skin.
PCT/EP2003/014068 2002-12-20 2003-12-11 Method for determining markers of human facial skin WO2004059001A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03789223A EP1573064A2 (en) 2002-12-20 2003-12-11 Method for determining markers of human facial skin
AU2003293839A AU2003293839A1 (en) 2002-12-20 2003-12-11 Method for determining markers of human facial skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002160928 DE10260928A1 (en) 2002-12-20 2002-12-20 Method for the determination of markers of human facial skin
DE10260928.4 2002-12-20

Publications (2)

Publication Number Publication Date
WO2004059001A2 WO2004059001A2 (en) 2004-07-15
WO2004059001A3 true WO2004059001A3 (en) 2005-03-03

Family

ID=32477976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/014068 WO2004059001A2 (en) 2002-12-20 2003-12-11 Method for determining markers of human facial skin

Country Status (4)

Country Link
EP (1) EP1573064A2 (en)
AU (1) AU2003293839A1 (en)
DE (1) DE10260928A1 (en)
WO (1) WO2004059001A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866233B1 (en) 2004-02-18 2008-02-08 Vincience DERMATOLOGICAL AND / OR COSMETIC COMPOSITION CONTAINING POLYPEPTIDES
FR2948021A1 (en) 2009-07-16 2011-01-21 Oreal COSMETIC USE OF LACRITIN-TYPE POLYPEPTIDES
WO2015031708A1 (en) * 2013-08-30 2015-03-05 The Procter & Gamble Company Methods of identifying cosmetic agents for treating periorbital dyschromia and systems therefor
JP6711968B2 (en) * 2014-01-10 2020-06-17 学校法人順天堂 Evaluation method of lymph node metastasis of endometrial cancer
NO344051B1 (en) * 2017-05-04 2019-08-26 Patogen As Novel virus in Fish and Method for detection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091700A2 (en) * 2000-05-30 2001-12-06 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
WO2002053773A2 (en) * 2001-01-03 2002-07-11 Henkel Kommanditgesellschaft Auf Aktien Method for determining skin stress or skin ageing in vitro
WO2002053778A2 (en) * 2001-01-05 2002-07-11 Genomicfx, Inc. Method for relative quantification of attached nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
CA2330790A1 (en) * 1998-05-04 1999-11-11 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Method and device for isolating nucleic acids
DE19819889A1 (en) * 1998-05-04 1999-11-11 Fraunhofer Ges Forschung Isolating nucleic acid from samples by binding to array of immobilized, random capture probes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091700A2 (en) * 2000-05-30 2001-12-06 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
WO2002053773A2 (en) * 2001-01-03 2002-07-11 Henkel Kommanditgesellschaft Auf Aktien Method for determining skin stress or skin ageing in vitro
WO2002053778A2 (en) * 2001-01-05 2002-07-11 Genomicfx, Inc. Method for relative quantification of attached nucleic acids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1573064A2 *
WATSON RACHEL E B ET AL: "A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 116, no. 5, May 2001 (2001-05-01), pages 672 - 678, XP002283191, ISSN: 0022-202X *

Also Published As

Publication number Publication date
DE10260928A1 (en) 2004-07-08
EP1573064A2 (en) 2005-09-14
AU2003293839A1 (en) 2004-07-22
WO2004059001A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
WO2002053773A3 (en) Method for determining skin stress or skin ageing in vitro
WO2002053774A3 (en) Method for determining homeostasis of the skin
EP2639301A3 (en) Polynucleotides encoding novel PCSK9 variants
ATE353974T1 (en) METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
WO2003087831A3 (en) Proteins involved in breast cancer
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
WO2003076592A3 (en) Novel method for delivery and intracellular synthesis of sirna molecules
EP2082747A3 (en) Treatment for Alzeimer's disease
WO2004111081A3 (en) Antigenic peptides of sars coronavirus and uses thereof
WO2006097205A3 (en) Method for conducting extracorporeal analysis of hair follicle cells
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
EA200601288A1 (en) 1,3-DIPHENYLPROP-2-EN-1-SHE DERIVATIVES, METHOD OF THEIR RECEIVING AND APPLICATION
WO2005089310A3 (en) Breath test for oral malodor
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
WO2004059002A3 (en) Method for determining the homeostasis of hairy skin
WO2005000335A3 (en) Use of genes differentially expressed during aging of liver for treatment and diagnosis
WO2004059001A3 (en) Method for determining markers of human facial skin
WO2004100886A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
EP2083018A3 (en) Compositions and methods relating to STOP-1
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
NO20060781L (en) Use of soluble CD164 in inflammatory and / or autoimmune disorders
WO2007134350A3 (en) Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR BY CA CN DZ EG ID IL IN JP KR MX NO NZ PL RU SG UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003789223

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003789223

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP